Vaping-Related Seizures - A Prospective Study
NCT06006442 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-10-10
Summary
This case-crossover study evaluates the association between vaping and seizures in patients of a large academic medical center who admits to vaping and hav a planned ambulatory EEG ordered.
Conditions
- Evaluate the Association of Vaping With Seizures
Interventions
- BEHAVIORAL
-
Vaping
Subjects will be smoking the vapnig products that they admitted to using at baseline in the personal life prior to this study
Sponsors & Collaborators
-
Dartmouth-Hitchcock Medical Center
lead OTHER
Principal Investigators
-
Peter S Tatum, DO · Dartmouth-Hitchcock Medical Center
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-09-30
- Primary Completion
- 2024-05-01
- Completion
- 2024-05-31
Countries
- United States
Study Locations
More Related Trials
-
Efficacy and Safety of Intravenous Phenobarbital in Neonatal Seizures
NCT04320940 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures
NCT01147003 ·Status: COMPLETED ·Phase: PHASE2
-
Intermittent Fasting in Refractory Epilepsy
NCT02311023 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
NCT02224690 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence Seizures
NCT06769659 ·Status: RECRUITING ·Phase: PHASE2
-
Epileptic Seizure in Epilepsy Patients After SARS-CoV-2 Vaccination
NCT05341713 ·Status: COMPLETED
-
A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.
NCT00740623 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients
NCT01422720 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures
NCT00422110 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Pharmacodynamics of Nasal and Buccal Midazolam Using EEG
NCT01316445 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures
NCT01397968 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of GWP42006 in People With Focal Seizures - Part B
NCT02365610 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.
NCT00425282 ·Status: COMPLETED ·Phase: PHASE3
-
Non-Interventional Study With LYRICA (Pregabalin) In Patients With Epilepsy As Adjunctive Therapy Of Partial Seizures To Reduce Seizure Frequency
NCT00684424 ·Status: COMPLETED
-
A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome
NCT04940624 ·Status: COMPLETED ·Phase: PHASE3
-
Epigenetics and Gut Microbiota in Children With Epilepsy
NCT04063007 ·Status: UNKNOWN ·Phase: NA
-
Buspirone Therapy for Localized Epilepsy
NCT01496612 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies
NCT05364021 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of Naloxone in Reducing Postictal Central Respiratory Dysfunction in Patients With Epilepsy
NCT02332447 ·Status: COMPLETED ·Phase: PHASE3
-
Serotoninergic Pathways in Sudden and Unexpted Death in Epilepsy (SUDEP)
NCT02788318 ·Status: TERMINATED
-
An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy
NCT00210652 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy
NCT03370120 ·Status: TERMINATED ·Phase: PHASE2
-
An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy
NCT00210522 ·Status: COMPLETED ·Phase: PHASE2
-
Topiramate for the Prophylactic Treatment of Cyclic Vomiting Syndrome in Children
NCT00286988 ·Status: TERMINATED ·Phase: PHASE4
-
Study to Assess Intracerebroventricular (ICV) Delivery of CT-010 in Subjects With Focal Seizures, With Temporal Lobe Onset With or Without Secondary Generalization
NCT04153175 ·Status: TERMINATED ·Phase: PHASE2